SEARCH

SEARCH BY CITATION

References

  • 1
    Jalan R, Williams R. Acute-on-chronic liver failure: pathophysiological basis of therapeutic options. Blood Purif 2002; 20: 252-261.
  • 2
    Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, et al. Acute-on-Chronic Liver Failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013 Mar 5. doi: 10.1053/j.gastro.2013.02.042. [Epub ahead of print].
  • 3
    Martín-Llahí M, Guevara M, Torre A, Fagundes C, Restuccia T, Gilabert R, et al. Prognostic importance of the cause of renal failure in patients with cirrhosis. Gastroenterology 2011; 140: 488-449.
  • 4
    Wong LP, Blackley LP, Andreoni KA, Chin H, Falk RJ, Klammer PJ. Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy. Kidney Int 2005; 68: 362-370.
  • 5
    Gonwa TA, Wadei HM. The challenges of providing renal replacement therapy in decompensated liver cirrhosis. Blood Purif 2012; 33: 144-148.
  • 6
    Witzke O, Baumann M, Patschan D, Patschan S, Mitchell A, Treichel U, et al. Which patients benefit from hemodialysis therapy in hepatorenal syndrome? J Gastroenterol Hepatol 2004; 19: 1369-1373.
  • 7
    Mitra KN, Genyk YS, Tokin C, Fieber J, Ananthapanyasut W, Ye W, et al. Impact of the etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis vs hepatorenal syndrome. Liver Transpl 2012; 18: 539-548.
  • 8
    Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000; 6: 277-286.
  • 9
    Bañares R, Nevens F, Larsen FS, Jalan R, Albillos A, Dollinger M, et al.; for RELIEF Study Group. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: The RELIEF trial. Hepatology 2012, Dec 5 (Epub ahead of print).
  • 10
    Kribben A, Gerken G, Haag S, Herget-Rosenthal S, Treichel U, Betz C, et al. Effects of fractionated plasma separation and adsorption on survival in patients with acute on-chronic liver failure. Gastroenterology 2012; 142: 782-789.
  • 11
    Sauer IM, Kardassis D, Zeillinger K, Pascher A, Gruenwald A, Pless G, et al. Clinical extracorporeal hybrid liver support—phase I study with primary porcine liver cells. Xenotransplantation 2003; 10: 460-469.
  • 12
    Ellis AJ, Hughes RD, Wendon JA, Dunne J, Langley PG, Kelly JH, et al. Pilot controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 1996; 24: 1446-1451.
  • 13
    Duan ZP, Zhang J, Xin X, Chen JM, He D, Brotherton JD, et al. Interim results of randomized controlled trial of ELAD™ in acute on chronic liver disease [abstract]. Hepatology 2007; 46: 274A.
  • 14
    Mazariegos GV, Patzer JF II, Lopez RC, Giraldo M, Devera ME, Grogan TA, et al. First clinical use of a novel bioartificial liver support system (BLSS). Am J Transplant 2002; 2: 260-266.
  • 15
    Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goehl H, et al. Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999: 23: 319330.
  • 16
    Schmidt LE, Sorensen VR, Svendsen LB, Hansen BA, Larsen FS. Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute-on-chronic liver failure. Liver Transpl 2001: 7: 10341039.
  • 17
    Jalan R, Sen S, Steiner C, Kapoor D, Alisa A, Williams R. Extra-corporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis. J Hepatol 2003: 38: 2431.
  • 18
    Di Campli C, Zocco MA, Gaspari R, Novi M, Candelli M, Santoliquido A, et al. The decrease in cytokine concentration during albumin dialysis correlates with the prognosis of patients with acute on chronic liver failure. Transplant Proc 2005: 37: 25512553.
  • 19
    Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000: 6: 277286.
  • 20
    Heemann U, Treichel U, Loock J, Philipp T, Gerken G, Malago M, et al. Albumin dialysis in cirrhosis with superimposed acute liver injury: a prospective, controlled study. Hepatology 2002; 36(4 Pt 1): 949958.
  • 21
    Sen S, Davies NA, Mookerjee RP, Cheshire LM, Hodges SJ, Williams R, et al. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transpl 2004: 10: 11091119.
  • 22
    Blei A. Efficacy of Albumin Dialysis (MARS) in patients with cirrhosis and advanced grades of hepatic encephalopathy: a prospective controlled, randomized multicentred trial. Hepatology (AASLD Abstract) 2004; 40: 726A.
  • 23
    Laleman W, Wilmer A, Evenepoel P, Elst IV, Zeegers M, Zaman Z, et al. Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute- on-chronic alcoholic liver failure. Crit Care 2006; 10: R108.
  • 24
    Rifai K, Ernst T, Kretschmer U, Bahr MJ, Schneider A, Hafer C, et al. Prometheus–a new extracorporeal system for the treatment of liver failure. J Hepatol 2003: 39: 984990.